{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:16:30Z","timestamp":1779203790258,"version":"3.51.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Candida albicans<\/jats:italic> (<jats:italic>C. albicans<\/jats:italic>) is the most prevalent opportunistic human pathogen, accounting for approximately half of all clinical cases of candidemia. Resistance to the existing antifungal drugs is a major challenge in clinical therapy, necessitating the development and identification of novel therapeutic agents and potential treatment strategies. Monoclonal antibody-based immunotherapy represents a promising therapeutic strategy against disseminated candidiasis. Protein mannosyltransferase (Pmt4) encodes mannosyltransferases initiating O-mannosylation of secretory proteins and is essential for cell wall composition and virulence of <jats:italic>C. albicans<\/jats:italic>. Therefore, the Pmt4 protein of <jats:italic>C. albicans<\/jats:italic> is an attractive target for the discovery of alternative antibody agents against invasive <jats:italic>C. albicans<\/jats:italic> infections. In the present study, we found that monoclonal antibodies (mAbs) C12 and C346 specifically targeted the recombinant protein mannosyltransferase 4 (rPmt4p) of <jats:italic>C. albicans<\/jats:italic>. These mAbs were produced and secreted by hybridoma cells isolated from the spleen of mice that were initially immunized with the purified rPmt4p to generate IgG antibodies. The mAbs C12 and C346 exhibited high affinity to <jats:italic>C. albicans<\/jats:italic> whole cells. Remarkably, these mAbs reduced the fungal burden, alleviated inflammation in the kidneys, and prolonged the survival rate significantly in the murine model of systemic candidiasis. Moreover, they could activate macrophage opsonophagocytic killing and neutrophil killing of <jats:italic>C. albicans<\/jats:italic> strain <jats:italic>in vitro<\/jats:italic>. These results suggested that anti-rPmt4p mAbs may provide immunotherapeutic interventions against disseminated candidiasis <jats:italic>via<\/jats:italic> opsonophagocytosis and opsonic killing activity. Our findings provide evidence for mAbs as a therapeutic option for the treatment of invasive candidiasis.<\/jats:p>","DOI":"10.3389\/fmicb.2022.992275","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T08:56:17Z","timestamp":1661244977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaojuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"9206","DOI":"10.1038\/s41598-020-65859-4","article-title":"The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo","volume":"10","author":"Antoran","year":"2020","journal-title":"Sci. Rep."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/antibiotics9120877","article-title":"Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium","volume":"9","author":"Arastehfar","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"126996","DOI":"10.1016\/j.micres.2022.126996","article-title":"Cell wall associated proteins involved in filamentation with impact on the virulence of Candida albicans","volume":"258","author":"Arita","year":"2022","journal-title":"Microbiol. Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1574-695X.2008.00502.x","article-title":"Recognition of Candida albicans Als3 by the germ tube-specific monoclonal antibody 3D9.3","volume":"55","author":"Beucher","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"671068","DOI":"10.3389\/fimmu.2021.671068","article-title":"Vaccine-induced immunological memory in invasive fungal infections - A dream so close yet so far","volume":"12","author":"Biswas","year":"2021","journal-title":"Front. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-National Prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/jof6010031","article-title":"Immunotherapy against systemic fungal infections based on monoclonal antibodies","volume":"6","author":"Boniche","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.riam.2018.07.005","article-title":"Anti-Candidaalbicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans","volume":"36","author":"Carrano","year":"2019","journal-title":"Rev. Iberoam. Micol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/mmbr.00032-07","article-title":"Candida albicans cell wall proteins","volume":"72","author":"Chaffin","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1080\/22221751.2020.1840927","article-title":"Preventing Candida albicans from subverting host plasminogen for invasive infection treatment","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mimet.2009.05.002","article-title":"Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces","volume":"78","author":"Coleman","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1128\/iai.65.8.3399-3405.1997","article-title":"Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats","volume":"65","author":"De Bernardis","year":"1997","journal-title":"Infect. Immun."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent Vulvovaginal candidiasis-A phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mib.2012.04.005","article-title":"Importance of the Candida albicans cell wall during commensalism and infection","volume":"15","author":"Gow","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.FUNK-0035-2016","article-title":"The fungal Cell Wall: structure, biosynthesis, and function","volume":"5","author":"Gow","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrmicro2711","article-title":"Candida albicans morphogenesis and host defence: discriminating invasion from colonization","volume":"10","author":"Gow","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e1008908","DOI":"10.1371\/journal.pgen.1008908","article-title":"An expanded cell wall damage signaling network is comprised of the transcription factors Rlm1 and Sko1 in Candida albicans","volume":"16","author":"Heredia","year":"2020","journal-title":"PLoS Genet."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ijmm.2011.04.004","article-title":"Adaptation, adhesion and invasion during interaction of Candida albicans with the host--focus on the function of cell wall proteins","volume":"301","author":"Hiller","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1009470","DOI":"10.1371\/journal.ppat.1009470","article-title":"Fungal cell wall: An underexploited target for antifungal therapies","volume":"17","author":"Ibe","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.intimp.2010.08.012","article-title":"Neutrophils: Cinderella of innate immune system","volume":"10","author":"Kumar","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1574-695X.2008.00465.x","article-title":"Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p","volume":"54","author":"Laforce-Nesbitt","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12272-011-0307-9","article-title":"Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis","volume":"34","author":"Lee","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in Candida albicans and Beyond","volume":"121","author":"Lee","year":"2021","journal-title":"Chem. Rev."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00018-007-7409-z","article-title":"Protein-O-mannosyltransferases in virulence and development","volume":"65","author":"Lengeler","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/ijms21082903","article-title":"Generation and characterization of single chain variable fragment against alpha-Enolase of Candida albicans","volume":"21","author":"Leu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/jcm.25.2.230-237.1987","article-title":"Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans","volume":"25","author":"Matthews","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/aac.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0215535","DOI":"10.1371\/journal.pone.0215535","article-title":"Novel mouse monoclonal antibodies specifically recognizing \u03b2-(1\u21923)-D-glucan antigen","volume":"14","author":"Matveev","year":"2019","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/iai.00001-10","article-title":"Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages","volume":"78","author":"Mckenzie","year":"2010","journal-title":"Infect. Immun."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0195721","DOI":"10.1128\/aac.01957-21","article-title":"Monoclonal antibodies targeting surface-exposed epitopes of Candida albicans Cell Wall proteins confer In vivo protection in an infection model","volume":"66","author":"Palliyil","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat rev dis primers."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cmi.2018.04.024","article-title":"Monoclonal antibodies as anti-infective products: a promising future?","volume":"25","author":"Pelfrene","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nport.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2958.2004.04401.x","article-title":"PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance","volume":"55","author":"Prill","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1128\/iai.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/aac.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1038\/s41467-018-07738-1","article-title":"Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis","volume":"9","author":"Rudkin","year":"2018","journal-title":"Nat. Commun."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/tid.12230","article-title":"Development of echinocandin-resistant Candida albicans candidemia following brief prophylactic exposure to micafungin therapy","volume":"16","author":"Ruggero","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1567-1364.2005.00017.x","article-title":"Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity","volume":"6","author":"Ruiz-Herrera","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/vaccines9101159","article-title":"The role of B-cells and antibodies against Candida vaccine antigens in invasive candidiasis","volume":"9","author":"Shukla","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.micres.2013.02.005","article-title":"Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions","volume":"168","author":"Sukhithasri","year":"2013","journal-title":"Microbiol. Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by anti-beta-glucan antibodies is associated with restricted beta-1, 3 glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jof6010022","article-title":"Monoclonal antibodies as tools to combat fungal infections","volume":"6","author":"Ulrich","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/21505594.2014.1000752","article-title":"Looking into Candida albicans infection, host response, and antifungal strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/21505594.2014.983015","article-title":"Vaccines in the treatment of invasive candidiasis","volume":"6","author":"Wang","year":"","journal-title":"Virulence"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1248\/bpb.b15-00475","article-title":"Vaccination with recombinant non-transmembrane domain of protein Mannosyltransferase 4 improves survival during murine disseminated candidiasis","volume":"38","author":"Wang","year":"","journal-title":"Biol. Pharm. Bull."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e1005617","DOI":"10.1371\/journal.ppat.1005617","article-title":"Mnn 10 maintains pathogenicity in Candida albicans by extending \u03b1-1, 6-mannose backbone to evade host Dectin-1 mediated antifungal immunity","volume":"12","author":"Zhang","year":"2016","journal-title":"PLoS Pathog."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/antibiotics9040155","article-title":"Monoclonal antibodies as an antibacterial approach Against bacterial pathogens","volume":"9","author":"Zurawski","year":"2020","journal-title":"Antibiotics (Basel)"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.992275\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T08:56:21Z","timestamp":1661244981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.992275\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":55,"alternative-id":["10.3389\/fmicb.2022.992275"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.992275","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"article-number":"992275"}}